Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 9
2003 4
2004 9
2005 6
2006 10
2007 10
2008 6
2009 13
2010 7
2011 18
2012 27
2013 44
2014 31
2015 32
2016 43
2017 45
2018 34
2019 28
2020 33
2021 51
2022 46
2023 43
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Results by year

Filters applied: . Clear all
Page 1
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH. Fujiwara T, et al. Mol Cancer Ther. 2021 Aug;20(8):1388-1399. doi: 10.1158/1535-7163.MCT-20-0591. Epub 2021 Jun 4. Mol Cancer Ther. 2021. PMID: 34088832 Free PMC article.
Dual antiplatelet therapy inhibits neutrophil extracellular traps to reduce liver micrometastases of intrahepatic cholangiocarcinoma.
Yoshimoto M, Kagawa S, Kajioka H, Taniguchi A, Kuroda S, Kikuchi S, Kakiuchi Y, Yagi T, Nogi S, Teraishi F, Shigeyasu K, Yoshida R, Umeda Y, Noma K, Tazawa H, Fujiwara T. Yoshimoto M, et al. Among authors: fujiwara t. Cancer Lett. 2023 Jul 28;567:216260. doi: 10.1016/j.canlet.2023.216260. Epub 2023 Jun 7. Cancer Lett. 2023. PMID: 37295551
Role of Tumor-Associated Macrophages in Sarcomas.
Fujiwara T, Healey J, Ogura K, Yoshida A, Kondo H, Hata T, Kure M, Tazawa H, Nakata E, Kunisada T, Fujiwara T, Ozaki T. Fujiwara T, et al. Cancers (Basel). 2021 Mar 3;13(5):1086. doi: 10.3390/cancers13051086. Cancers (Basel). 2021. PMID: 33802565 Free PMC article. Review.
Clinical Impact of Sarcopenia on Gastric Cancer.
Kuwada K, Kuroda S, Kikuchi S, Yoshida R, Nishizaki M, Kagawa S, Fujiwara T. Kuwada K, et al. Among authors: fujiwara t. Anticancer Res. 2019 May;39(5):2241-2249. doi: 10.21873/anticanres.13340. Anticancer Res. 2019. PMID: 31092415 Review.
p53 Replacement Therapy for Cancer.
Tazawa H, Kagawa S, Fujiwara T. Tazawa H, et al. Among authors: fujiwara t. Recent Results Cancer Res. 2016;209:1-15. doi: 10.1007/978-3-319-42934-2_1. Recent Results Cancer Res. 2016. PMID: 28101684 Review.
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody.
Nishiwaki N, Noma K, Ohara T, Kunitomo T, Kawasaki K, Akai M, Kobayashi T, Narusaka T, Kashima H, Sato H, Komoto S, Kato T, Maeda N, Kikuchi S, Tanabe S, Tazawa H, Shirakawa Y, Fujiwara T. Nishiwaki N, et al. Among authors: fujiwara t. Cancer Immunol Immunother. 2023 Jul;72(7):2029-2044. doi: 10.1007/s00262-023-03378-7. Epub 2023 Feb 10. Cancer Immunol Immunother. 2023. PMID: 36764954 Free PMC article.
Feasibility of local therapy for recurrent pancreatic cancer.
Sato H, Yoshida R, Yasui K, Umeda Y, Yoshida K, Fuji T, Kumano K, Takagi K, Yagi T, Fujiwara T. Sato H, et al. Among authors: fujiwara t. Pancreatology. 2022 Sep;22(6):774-781. doi: 10.1016/j.pan.2022.05.004. Epub 2022 May 24. Pancreatology. 2022. PMID: 35641368 Review.
495 results